|
|
Volumn 292, Issue 6, 2005, Pages 96-101
|
|
DOUBT is their product
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BERYLLIUM;
CHEMICAL INDUSTRY;
DATA REDUCTION;
DISEASES;
DRUG PRODUCTS;
EPIDEMIOLOGY;
HEALTH RISKS;
INDUSTRIAL RESEARCH;
LAWS AND LEGISLATION;
CHRONIC BERYLLIUM DISEASE (CBD);
INDUSTRY GROUPS;
SCIENTIFIC UNCERTAINTY;
TOXICOLOGY;
PUBLIC POLICY;
BERYLLIUM;
LACTONE;
ROFECOXIB;
SULFONE;
ARTICLE;
DRUG INDUSTRY;
DRUG LEGISLATION;
GOVERNMENT;
MANAGEMENT;
PSYCHOLOGY;
PUBLIC HEALTH;
RESEARCH;
RISK FACTOR;
UNITED STATES;
BERYLLIUM;
DRUG INDUSTRY;
GOVERNMENT;
GOVERNMENT AGENCIES;
LACTONES;
LEGISLATION, DRUG;
POLICY MAKING;
PSYCHOLOGY;
PUBLIC HEALTH;
RESEARCH;
RISK FACTORS;
SULFONES;
UNITED STATES;
|
|
EID: 20444507591
PISSN: 00368733
EISSN: None
Source Type: Journal
DOI: 10.1038/scientificamerican0605-96 Document Type: Review |
|
Times cited : (111)
|
|
References (0)
|